Trijardy XR 1000 mg/1

Trijardy XR 1000 mg/1 combines empagliflozin, linagliptin, and metformin hydrochloride for managing type 2 diabetes. This extended-release tablet supports blood sugar control and may reduce cardiovascular risks. Ideal for adults with type 2 diabetes requiring combination therapy.

Trijardy XR 1000 mg/1 is used to manage type 2 diabetes in adults. It combines three active ingredients—empagliflozin, linagliptin, and metformin hydrochloride—to help control blood sugar levels. This medication is typically prescribed for individuals who need combination therapy to achieve optimal glycemic control. It may also be used to reduce the risk of cardiovascular events in certain patients.

Common effects of Trijardy XR 1000 mg/1 may include urinary tract infections, hypoglycemia, and gastrointestinal issues like diarrhea or nausea. Some users may experience increased urination or dizziness. These effects vary and are not experienced by everyone. Always consult a healthcare provider for personalized advice.

Trijardy XR 1000 mg/1 should be handled with care. It is important to follow the prescribed dosage and administration instructions. Avoid alcohol while taking this medication, as it may increase the risk of side effects. Store the tablets in a cool, dry place away from direct sunlight. Always inform your healthcare provider about any other medications you are taking.

Trijardy XR 1000 mg/1 may interact with certain medications, including other diabetes drugs, diuretics, and some antibiotics. Alcohol can increase the risk of side effects. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions. This medication may also interact with certain medical conditions, so always consult a healthcare provider before starting.